Refreshed just now
EVELIQURE BIOTECHNOLOGIES GMBH — National Institutes of Health award 75N93020C00048
Department of Health and Human Services
At a glance
- Value
- $12.9M obligated
- Awarded to
- Eveliqure Biotechnologies GmbH
Lifecycle
1 noticeAwardNational Institutes of HealthAug 31NIH awarded Eveliqure Biotechnologies GmbH contract 75N93020C00048 to fund cGMP manufacturing and lot release of the Shigetec vaccine for Phase 2 trials.$12.9M obligated75N93020C00048Eveliqure Biotechnologies GmbHBiotechLifecycle15 linked